A Phase 2 Randomized Controlled Study Using Omalizumab As An Adjunct Therapy During Multi-Allergen Oral Immunotherapy In Food Allergic Individuals To Test Long-Term OutcomesR. S. Chinthrajah,S. Andorf,N. Purington,D. Kumar, A. Long, K. O'Laughlin,S. Sicherer, H. Sampson,A. Cianferoni, T. B. Whitehorn, D. Petroni, M. Makhija, R. G. Robison, M. Lierl, S. Logsdon,M. Desai,S. J. Galli, A. Assa'Ad, J. Pongracic,J. M. Spergel,J. Tam,S. Tilles,J. Wang,K. NadeauALLERGY（2019）引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
